Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
about
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.Botulinum Toxin Treatment in Multiple Sclerosis-a Review.Management of neurogenic bladder in patients with multiple sclerosis.
P2860
Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
@en
type
label
Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
@en
prefLabel
Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
@en
P2093
P2860
P1476
Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.
@en
P2093
Anette S Fjeldstad
Gael J Yonnet
John W Rose
Noel G Carlson
P2860
P356
10.7224/1537-2073.2012-031
P577
2013-01-01T00:00:00Z